CA2076647C - Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them - Google Patents

Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them Download PDF

Info

Publication number
CA2076647C
CA2076647C CA002076647A CA2076647A CA2076647C CA 2076647 C CA2076647 C CA 2076647C CA 002076647 A CA002076647 A CA 002076647A CA 2076647 A CA2076647 A CA 2076647A CA 2076647 C CA2076647 C CA 2076647C
Authority
CA
Canada
Prior art keywords
fructo
oligosaccharides
branched
fructose
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002076647A
Other languages
French (fr)
Other versions
CA2076647A1 (en
Inventor
Paul Coussement
Leen De Leenheer
George Smits
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Raffinerie Tirlemontoise SA
Original Assignee
Raffinerie Tirlemontoise SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raffinerie Tirlemontoise SA filed Critical Raffinerie Tirlemontoise SA
Publication of CA2076647A1 publication Critical patent/CA2076647A1/en
Application granted granted Critical
Publication of CA2076647C publication Critical patent/CA2076647C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14Organic oxygen compounds
    • A21D2/18Carbohydrates
    • A21D2/181Sugars or sugar alcohols
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/154Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
    • A23C9/1544Non-acidified gels, e.g. custards, creams, desserts, puddings, shakes or foams, containing eggs or thickening or gelling agents other than sugar; Milk products containing natural or microbial polysaccharides, e.g. cellulose or cellulose derivatives; Milk products containing nutrient fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/346Finished or semi-finished products in the form of powders, paste or liquids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L21/00Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
    • A23L21/10Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products
    • A23L21/12Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products derived from fruit or vegetable solids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L9/00Puddings; Cream substitutes; Preparation or treatment thereof
    • A23L9/10Puddings; Dry powder puddings
    • A23L9/12Ready-to-eat liquid or semi-liquid desserts, e.g. puddings, not to be mixed with liquids, e.g. water, milk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0051Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Fructofuranans, e.g. beta-2,6-D-fructofuranan, i.e. levan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G2200/00COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
    • A23G2200/06COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing beet sugar or cane sugar if specifically mentioned or containing other carbohydrates, e.g. starches, gums, alcohol sugar, polysaccharides, dextrin or containing high or low amount of carbohydrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Materials Engineering (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)

Abstract

Branched fructo-oligosaccharides consisting of a chain which comprises mainly fructose units and has a preferred chain length of 2 to 15 units, on which are fixed one or more side chains mainly composed of fructose units. The length of the side chain, which may be straight or branched, is of 1 to 10 units. A composition consisting of one or more of the above mentioned branched fructo-oligosaccharides and, particularly, mixtures comprising, apart from the branched fructo-oligosaccharides, other ingredients such as proteins, lipids or fatty acids, carbohydrates, fibres and other additives, are also described.

Description

BRANCHED FRUCTO-OLIGOSACCHARIDES METHOD FOR
OBTAINING THEM AND USE OF PRODUCTS CONTAINING THEM
Subiect of the invention The present invention relates to branched fructo-oligosaccharides which particularly exhibit sweetening and bulking agent properties.
It also relates to the products which contain these branched fructo-oligosaccharides and to their use.
Finally, the present invention applies to the particular processes for their preparation.
Summary of the prior art A sedentary lifestyle where physical labor has nearly disappeared has considerably changed food require-ments.
As a general rule, too much is eaten and often in an unbalanced manner. Too much fat, too much salt, too few so-called slow (complex) sugars and too little fiber.
In particular, the proportion of so-called slow sugars in our diets has fallen considerably, thus limiting their energy contribution.
Currently, the so-called rapid sugars and fats supply the principal energy contributions in our diet . It has been known for a long time that an unbalanced diet leads in the long term to serious deficiencies or even to diseases, for example cardiovascular diseases.
Additionally, a diet which is poor in fibers seems to be the cause of many digestive system disorders.
There is increasing awareness of the close connection which exists between the general state of health and the eating habit. There is also a tendency to adapt the diet or more particularly the dietetics to individual needs.
Inter alia, the development and the use of sweeteners with a high sweetening power have allowed the consumer to better adapt his diet to his needs. These sweeteners make it possible to give a sweet taste to the foods which contain them without having to have recourse to high-calorie sugars.
In this way, beverages with a negligible calorie
- 2 - PCT/BE91/00014 contribution have, for example, appeared on the market.
On the other hand, the use of bulking agents is often essential in a range of foods such as pastry, confectionery, etc.
Sucrose, or glucose or fructose syrups are usually used as bulking agents. Nevertheless, these sugars are highly calorific.
Again, "sugar substitutes" have appeared on the market which are characterized by a lower calorific contribution.
More particularly, the ideal bulking agent would be a low- or noncalorific natural product, which is safe to use, wholesome, well tolerated by the body, without any particular taste and which can be used in a similar way to sucrose.
The bulking agents meeting these requirements have a high commercial potential.
The bulking agents are low-calorie if they satisfy one of the two following conditions:
- of being only partially or not at all absorbed into the blood via the small intestine;
- o~ being absorbed into the blood via the small intestine but not metabolized or only slightly meta-bolized by the body.
The use of linear fructo-oligosaccharides as bulking agents is known. These sugars, whose natural presence in food has been known for a long time, can be obtained enzymatically (see Albon et al., J. Chem. Soc.
( 1953 ) , p. 24-27; Kawai et al . , Agr. Biol. Ghem. Vol . 37, No. 9 (1973, p. 2111-2119; Tomoda et al., Kyoritsu Yakka Daigaku Nempo vol. 20 (1975) p. 1-8) or by hydrolysis of inulin.
The linear fructo-oligosaccharides can be pro-duced industrially from sugar as described in the docu-ment GB-A-2000144 by obtaining products of GFn type (G = Glucose, F = Fructose, n = 2 to 5, bonds of the type B (1-2), or by hydrolysis of inulin, producing a mixture of GFn and Fn (n = 2 to 10 and more).
These fructo-oligosaccharides have the following ~~'~a~~.~~'~
- 3 - PCT/BE91/00014 advantageous properties: neutral and sweet taste, absence of smell, low calorific. value, dietary fiber effect, bifidogenic effect and natural and nontoxic character.
Furthermore, these products have technological charac-teristics such that they can be used according to the standard methods for preparation of sugars and syrups.
Likewise, 'they can be used as sugar substitute in standard applications, for example as sweeteners in foods and beverages or as base materials or excipients for the preparation of pharmaceutical products.
Furthermore, they can be used in any industrial application envisaged for sugars and syrups, such as the production of adhesives, humidifiers, insecticides, colorants, tanning agents, electrical insulators, binders for foundry cores or, in a more general way, as softeners and/or thickeners and, of course, more particularly in the dietary field as a groduct of low calorific value or as a product with a dietary fiber effect or with a bifidogenic effect.
As a general rule, the low-calorie bulking agents are only partially absorbed in the small intestine and, for this reason, pass into the large intestine where they undergo, partially or totally, a fermentation due to the intestinal flora.
This is a natural process which all fibers undergo and which is the cause of the beneficial effect arising from the fibers.
The bulking agent is converted by fermentation in the large intestine into a range of reaction products of which the principal ones are volatile fatty acids (VFA) and gases such as COZ, HZ and, in certain cases, CH4.
These gases are principally removed by the blood and the lungs or, in part, by flatulence.
During the passage of the bulking agent through the small intestine, the molecules of the latter absorb water and pass into the large intestine. This can cause osmotic diarrheas when the bulking agent is taken in large quantities. Of course, this effect depends essen tially on the water-absorbing power of the bulking agent 2~~~~1.~'~
- 4 - PCT/BE91/00014 and is, in general, higher in the case of substances based essentially on monosaccharides than in the case of saccharides with a higher degree of polymerization.
In particular, the linear fructo-oligosaccharides which are not absorbed or only slightly absorbed in the stomach and the small intestine are found almost entirely in the large intestine and, as a result of their oligo saccharide nature (low degree of polymerization), they cause osmotic diarrheas only when they are taken in large quantities.
However, when they are ingested in large quan-tities, the linear fructo-oligosaccharides can give rise to a variety of unpleasant consequences (and of dis-orders) due principally to their fermentable character:
increased flatulence, intestinal cramps, gastric noises, soft stools or even diarrheas.
More precisely, traces of linear fructo-oligo-saccharides are not found in stools, even when large quantities have been ingested: this shows that they have undergone complete fermentation by the intestinal flora.
In fact, it has been proved that the linear fructo-oligosaccharides are degraded by bacteria belong ing to the Bifidobacterium family, which shows the bifidogenic character of the linear fructo-oligo saccharides.
It is well understood that these various pheno-mena depend on the dose ingested, the sensitivity of the person concerned, the form in which the product contain-ing the fructo-oligosaccharides is given, the time span over which the amounts were ingested, possibly the period of adaptation to the product and the composition of the other ingredients and, finally, the nature of the bulking agent ingested.
Moreover, these are disorders which have been known for a long time, in particular during the ingestion of large quantities of plums, cherries or onions.
These undesirable side effects are the cause of the fact that the use of these low-calorie bulking agents is not unlimited.
- 5 - PCT/BE91/00014 In particular, for certain agents, legislation has established a maximum daily dose. This dose amounts, for example, to 30 g for certain sugar alcohols (poly-alcohols derived from sugar).
Even in the case of bulking agents consisting of linear fructo-oligosaccharides, these disadvantages persist although the latter are in general better tolera-ted by the body, probably due to the fact that the osmotic effect is less than for certain sugar alcohols.
More particularly, it has become apparent that the long chain fructo-saccharides, such as inulin, cause osmotic phenomena which are less marked still. However, the negative effects due to fermentation by the intes-tinal flora have not completely disappeared.
Furthermore, these fructo-oligosaccharides exhibit a solubility which decreases and a viscosity which increases as the chain length increases.
The result of this is that the long chain fructo saccharides do not exhibit all the appropriate technological properties for use as bulking agents instead and in place of sugar.
Moreover, fructose polymers have already been described in the following documents:
- In Indian Journal of Biochemistry & Biophysics, vol.
13, Dec. 1976, pp. 398-419, Satyanarayana describes branched oligosaccharides which may be found in small quantities in nature. It seems that fructo syltransferase which is isolated from the vera Cruz agave is unable to synthesize this branched oligo saccharide; it is thus not possible to obtain it in large quantities.
- Likewise, in Liebigs Annalen der Chemie, 614, 126 (I958), Schlubach described branched oligosaccha rides which can be found in small quantities in nature.
- In Liebigs Annalen der'Chemie, 635, 154 (1959), Schlubach also described natural products consisting of polymerized and branched fructose units which cannot be obtained naturally in large quantities.
- 6 -In Agric. Biol. Chem., 52(4) 1303-1304 (1988), Muramatsu describes how oligosaccharides whose structure is identical to the products described in the patent EP-0307158 are obtained From sucrose via a microorganism.
- In Carbohydrate Research, 180 (1988), 315-324, Brasch et al.
described a .fructose polymer (average chain length: 18) where 15% of the fructose units contain a branching point at t:he Oj6 position.
Nevertheless, as a result of their excessively great chain length, these r~lecules do not constitute a suitable bulking agent.
- The patent EP-0,307,158 of Nihon Shokuhin descr_i.bes a fructose poly~r where a branching point appears on a glucose unit.
- The document J. of Chem. Soc., p. 1822-1830 (1951) describes a branched polyfructose, wherein the number of fructose units are estimated between 18 and 30 units.
- The document TLi.ebigs annalen der Chemie, 647, 41 ( 1961 ) describes fxucto-oligosaccharides which present either a single branch upon the glucose unit (the neokestose or the neobifuncose series), or a single branch upon a fructose unit (the kestose, the bifurcose or the phlein derivatives of the bifurcose).
- The docui~nt New Zealand J. of Thechnologie, vol. 1, N° 1, p. 27-31 (1985) describes a branched fructo-oligosaccharide extracted from "cordyline australis" with an average chain length of 18 units.
- The patent application GB-2 105 338 describes an enzymatic treatment process allaaing the obtention of a non-branched oligosaccharide constituted of one to four fructose molecules linked to a sucrose molecule.
Aims of the invention The present invention aims to produce bulking agents which do not exhibit or which exhibit in a greatly abated way, the undesirable digestive disorders due to the conventional bulking agents.
Another aim of the present invention is to supply a bulking agent which exhibits the same advantageous properties as the linear fructo-oligosaccharides, such as neutral and sweet tastes, absence of smell, low calorific value, dietary fiber effect, bifidogenic effect and natural and nontoxic character of the product.
Another aim of the present invention consists in producing products which are more soluble.
Another aim of the present invention consists in supplying products which can be used in a conventional way, using the standard processes for preparing sugars and syrups.
Other camplementaxy airs of the present. invention ie in -the use of the product of the invention as a sweetener, as a low-calorie or weakly cariogenic food, as a bifidogenic product or a produces with a REPhACEMENT SHEET

fiber effect, as a means of lowering the cholesterol level or of improving the condition of the intestinal flora, etc.
Other aims and advantages will become apparent in the description which follows.
Description of the invention The present invention relates to branched fructo-oligosaccharides consisting of a main chain and of one or more side chains, characterized in that the main chain and the side chains) consist mainly of fructose units, the main chain contains from 2 to 15 units and at least one branching point on one fructose unit, the branching of said at least one branching point consisting of a fructose-fructose bond, with the exception of the natural products.
The present invention also relates to a c~sition consisting-of one or mare branched fructoroLigosaccharides according to the invention and, more particularly, to mixtures consisting, in addition to the branched fructo--oLigosarchar~.de ( s ) , of other ingredients such as Pr~~~ ~-i-Pig or fatty acids, carbohydrates, fibers and other additives. -In particular, these ingredients may be products taken frcsn the following nonlimiting list: sweeteners such as saccharose, products of the hydrolysis of the starch, palatinose, sucrose, glucose, fructose, glucose syrups or polyalcohols derived fran sugar such as sorbitol, xyLitol, erythritol, mannitol, maltitol, lactitol or :isan~lt~ leucritol;
bulking agents such as polydextrose, cellulose, hemicellulose or fructoroligosaccharides; or, again, s~a~eeteners with a high sweetening power such as aspartame, acesulfame, saccharin, stevioside, sucralose and other dipeptide sweeteners, etc.
The products according to the invention are particularly suitable for use in human or animal feeding as bulking agents, as sweeteners, as low-calorie or weakly cariogenic foods, as bifidogenic prod~u~cts or products which improve the intestinal flora, as products with a dietary fiber effect, as agents for reducing the cholesterol 3 0 l~- ~. again, to improve the tolerance of food products. Zhe present invention relates also to a pharmaceutical cat~osition comprising a branched fzvcto-oligosar_chari~de accor<lir~g to the invention and possibly a suitable carrier.
Finally, the present invention also relates to processes for preparing these branched fructoroLigosaccharides.

-7a-In nar+;cular, the products according to the invention can be obtained by synthesis from sugar or fran mixtures of fructose, optionally through the intexmedi.acy catalysts or enzymes or by interaction of various enzymes with the sucrose of the fructo-oLigosaccharides, inulin or fructans or chemically, that is to say by polymerization, principally of fructose, or by extraction frcm vegetable sources containing the said fructans, or, 2~~~61~~

again, by hydrolysis of branched fructose polymers.
The fruc-to-oligosaccharides according to the invention can, in particular, be obtained from sucrose, fructose syrups, fructose in the crystalline form, fructans, levans, inulin, their hydrolysis products or, finally, products extracted from plants containing fructans.
Through the intervention of various enzymes, such as for example fructosyltransferase, levansucrase, etc., it is also possible selectively to form bonds which make it possible to implant fructose units at specified positions on other fructose units in the oligosaccharide chains. Enzymes may be used either consecutively or simultaneously. Preferably, enzymes will be used which preferentially form different bonds from those of the substrate.
For the production of branched fructo-oligo saccharides, optionally enzymatic processes of condensa tion or of synthesis, or, again, hydrolytic processes may be used.
By condensation of fructose monomers, it is possible to obtain an "at random" polymerization which may be followed by a chromatographic separation.
It is also possible to obtain branched fructo oligosaccharides by hydrolysis of synthesized branched molecules or of those which exist in the natural state.
In this case, it is also possible to use several different hydrolysis techniques, especially the technique of acid hydrolysis, the technique of alkaline hydrolysis or the technique of enzymatic hydrolysis.
In particular, specific enzymatic hydrolysis such as, for example, the interaction of endoinulase with the mixture of branched fructans isolated from Cordyline australis ("cabbage tree"), which specifically attacks the (i(2~1) bonds, gives rise to branched fructo-oligo-saccharides.
The result depends on the nature of the starting material and on the hydrolysis technique used and, optionally, the enzymes used for the hydrolysis process Y C

and the reaction conditions. According to the reaction conditions, new branching points may be produced during the hydrolysis reaction of branched or linear molecules.
Reducing end groups can, in addition, be chemi tally converted, for example by oxidation, by reduction or by hydrogenation, etc.
The present invention also relates to a process which makes it possible to render the ir~ulin more soluble by a very incomplete hydrolysis, followed by a branching reaction.
The processes used and the products obtained are better described with the help of the examples which follow.
Example 1: Preparation of branched fructan polymers by hydrolysis A mixture of branched fructans can be obtained from the "cabbage tree" (Cordyline australis) by extrac-ting with methanol, washing with water followed by precipitation in an acetone/ethanol solution and drying.
The substances obtained consist principally of glucose and fructose units in a ratio of 1 to 16, arranged in chains with an average degree of polymeriza-tion equal to 18, where approximately 15$ of the fructose units have a branching point.
A 25° Brix solution is heated to 90°C and then 2N HC1 is rapidly added until a pH of 2.5 is obtained.
After reacting for 2 minutes, the hydrolysis is stopped by adding NaOH (3M) until a pH of 6.5 is obtained.
This solution is then filtered and demineralized by a double treatment on cationic and anionic ion exchangers. The glucose, the fructose and the sucrose formed by hydrolysis are then removed by chromatographic separation on a cationic column in the potassium form.
The mixture of oligosaccharides thus obtained contains between 5 and 10~ of mono- and disaccharides and from 90 to 95~ of oligosaccharides. The average degree of poly-merization of the composition thus obtained is approxi-mately 5 and approximately 40~ of the molecules therein are branched.

ExAMPLE 2: Preparation of the product according to the invention by synthesis In this case, the enzyme levansucrase, derived from Bacillus subtilis, is used.
It has been observed that 'this enzyme, when incu-bated under suitable conditions in the presence of sucrose and of fructo-oligosaccharides of the p(2-~1) type, forms branched fructo-oligosaccharides.
In this example, the base fructo-oligosaccharides used are obtained by enzymatic hydrolysis of inulin by endo-inulinase obtained from the enzymatic preparation Novozyme 230.
A 40° Brix solution consisting of 50~ sucrose and 50$ base fructo-oligosaccharides is prepared in a 0.05M
phosphate buffer solution at a pH of 6.
A solution of levansucrase which contains 20 U/ml - 1 U being the quantity of enzyme necessary to release 1 micromole of glucose per minute - is added to the mixture in such a way as to obtain 4 U of levansucrase per gram of dry carbohydrate matter in the mixture. The solution is then incubated at 30°C for 18 hours in an orbital shaker (150 rev/min). The enzymatic reaction is then halted by cooking the reaction mixture for 5 minutes. Linear, long chain p-fructans (DP>12) are separated off by precipitating with 80~ ethanol.
After centrifuging (30 minutes at 5000 rev/min) and evaporating off the ethanol under vacuum, the solu-tion is demineralized on ion exchangers such as described in Example 1.
Th2 mixture obtained is then subjected to a chromatographic analysis. The chromatogram is represented in Figure 1.
The reaction mixture contains at this point approximately 27$ glucose, 3~ fructose, 3~ sucrose and 67~ fructans with a DP>2, of which approximately 60~ has a DP<12 and 40~ has a DPzl2. This fraction with a DPzl2 cannot be precipitated with 80~ ethanol, which is an indication of its branched nature. Approximately 40~ of the molecules which have a DP of 3 to 12 are branched 2~'~~~~~~f {cf. chroma.togram Figure 1).
The monosaccharides are principally removed by chromatographic separation.
The final product thus obtained contains approxi matel.y 90 to 95% of oligosaccharides with an average degree of polymerization equal to 4.5-5 and where X10 to 50% of the molecules are branched.
The branched fructo-oligosaccharides exhibit unexpected tolerance properties while still retaining the other advantageous properties of linear fructo oligosaccharides: neutral and sweet taste, absence of smell, low calorific value, dietary fiber effect, bi.fido-genic effect and natural and nontoxic character.
The branched fructo-oligosaccharides can also be used as sugar substitutes in all the standard and indus trial applications described for linear frucao-oligosacc harides.
The improved tolerance of these branched fructo--oligoposaccharides was demonstrated by carrying out the following in-vitro and in-vivo tests:
1. IN-VITRO Tests Fresh fecal materials from male subjects in good health were homogenized with 5 times their caeight of isotonic NaKCl in an anaerobic environment. Five 10 ml aliquot fractions of this homogenized mixture were used per test group.
As reference test group, 5 incubations were carried out in test tubes containing 20 g~l of a mixture of fructo-oligosaccharides consisting of 5% of glucose, fructose and sucrose, 35% of GF2, 50% of GF3 and 10% of GF4 (G = glucose, F = fructose).
As second test group, 5 incubations were carried out in test tubes containing 20 ml/1 of the mixture of branched fructo-oligosaccharides described in Example 1.
The test tubes are sealed with a sheet of paraf-fin wax whose displacement indicates the production of gas.
The formation of gas was monitored for 12 hours.
It is expressed in centimeters of displacement per hour.
R~P~AC~ra~rrx sH~ET

~~~o~~'l These tests show that the formation of gas per hour in the case of branched fructo-oligosaccharides reaches only 35~ of that dine to linear fructo-oligosaccharides.
2. IN-VIVO Tests During an experiment carried out on three male subjects sensitive to fermentation in the large rotes-.
tine, various quantities of fructo-oligosaccharides were mixed in fruit juices taken at breakfast, this breakfast usually consisting o.f fruit juice, bread and coffee in the usual quantities. The dose introduced is gradually increased in 10 g doses from an initial dose also of 10 g. Between two test breakfasts, at least two days elapse without any test.
The reactions of the subjects were recorded for each concewtration and more specifically as regards the following criteria: flatulence, gastric noises, intes-tinal cramps, soft stools and diarrhea. The "stopping dose" is defined as the first dose where one or more of these side effects are felt to be uncomfortable.
The substances tested which were introduced into the fruit juice are the following:
substance A: mixture of linear fructo-oligosaccharides such as described above in the prior art;
substance B: mixture of branched fructo-oligosaccharides such as described in Example 2.
Substance C: mixture containing 505 of substance A and 50~ of substance B.
The results obtained are dP~r~r;hA~a ;" ,-,", following table:
STOPPING DOSE A B C
VOLUNTEER 1 20 g 40 g 30 g VOLUNTEER 2 30 g 60 g 50 g VOLUNTEER 3 40 g 60 g 50 g From this table, it can be concluded that the branched fructo-oligosaccharides are tolerated better than the linear oligosaccharides and that by introducing a certain quantity of branched fructo-oligosaccharides into a mixture which also comprises linear fructo-oligosaccha.rides, the tolerance of this mixture is increased.
Properties Low-calorie product The branched fructo-oligosaccharides are not hydrolyzed by human digestive enzymes. These substances thus have a low calorie contribution.
Weakly cariog_enic product The branched fructo-oligosaccharides are less cariogenic than sucrose. This is explained by the fact that they are not used as substrate for the formation of dental plaque and that they are less capable of causing the formation of acid by the oral flora.
Products with bifidoQenic activity and which improve the intestinal flora The branched fructo-oligosaccharides have a selective bifidogenic effect: they stimulate in a speci-fic way the growth of the bifid population in the large intestine. This is explained by the fact that these fructo-oligosaccharides are used as an energy source by the bacteria belonging to the Bifidobacteria group, whereas other bacteria are much less able to use this substrate. In particular, a certain number of putref-active bacteria (such as Salmonella and Clostridium) have their growth limited, which brings about a qualitative and quantitative improvement in the intestinal flora.
Product with dietary fiber effect and which reduces the cholesterol level The fructo-oligosaccharides have a dietary fiber effect: they reduce the intestinal transit time and increase the fecal mass. This is explained by the fact that these fructo-oligosaccharides are not absorbed in the small intestine and pass into the large intestine where they undergo a fermentation. These fructo-oligo-saccharides also cause a reduction in the blood chole-sterol level as a result of their dietary fiber effect.
Diuretic agent The branched frueto-oligosaccharides can be used for the 2~~~~~ ~~

prevent ion or the treatment of al.l those disorders which may be caused by the presence of products such as, for example, accumulated degradation products which can be the cause of kidney disorders, liver disorders or of cancer, etc.
Product which improves the tolerance of other products It is already known that branched fructo-oligo-saccharides are tolerated better than their linear analogs.
Indeed, the branched molecules constitute fermen-tation substrates which are more difficult for the intestinal flora; the fermentation is thus retarded by the presence of these molecules.
It is thus possible to improve the tolerance of fermentable foods by adding branched fructo-oligo saccharies to the diet, due to the reduction and slowing down of the fermentation phenomena.
Solubility of the product The branched fructo-oligosaccharides have a higher solubility than that of the linear compounds, which allows them to be used more readily in a certain number of products (cold sparkling or dairy drinks, other dairy products, confectionery, biscuits, etc.j where high concentrations of sugars must be used.
The combination of these last two properties, namely the increased tolerance of the branched fructo-oligosaccharides and the increased solubility of the product according to the invention favor their use as bulking agents.
Increased stability in acids medium The branched fructo-oligosaccharides have better stability in acidic medium than the linear compounds, and this makes it possible to limit their degradation ( forma-tion of saccharides such as fructose, glucose and sucrose) during the manufacture and the storage of acidic foods and to guarantee that the latter have characteris-tics which are more constant during their lifetime.
The increase in the stability in acidic medium was revealed during a comparative experiment carried out with two substances:
Substance A: mixture of linear fructo-oligosaccharides containing 5~ of glucose, fructose and sucrose 35~ of GF2 50~ of GF3 10~ of GF4 Substance B: mixture of branched fructo-oligo-saccharides as described in Example 1~
Each of 'the substances A and B was taken up in 10 ° Brix aqueous solution; the pH was then ad justed to 3.5 with the aid of hydrochloric acid.
The solutions thus obtained were stored for several weeks at 20°C. The stability of the fructo oligosaccharides in these solutions was followed by the development of glucose and sucrose contents {determined by gas chromatography) during storage.
The results obtained are described in the table below:
Table: Fructose, glucose and sucrose content in ~
Storage time Substance at 20 A B
C and pH = 3.5 4 weeks 18 11 8 weeks ~ 32 21 Applications The branched fructo-oligosaccharides can be incorporated into foods or prepared in the form of granules or tablets. In the latter case, they can be used as oral pharmaceutical compositions, for example to selectively stimulate the growth of the bifid population, as a diuretic, etc.
The frudto-oligosaccharides have properties comparable to those of sugar and glucose syrups; they can therefore be used in the same way. They can replace sugar and glucose syrups in the majority of applications, . CA 02076647 2000-03-30 especially in the following products:
- confectionery (sweets, etc.), - jelly products (gums, etc.), - chocolate-based preparations, - chewing gum, biscuits, .
- ice creams and sorbets, -- dairy products, ' - fruit-based drinks, - fruit jams and preparations, caramels, - phanaaceutical preparations, etc.
The branched fructo-oligosaccharides have, in particular, suitable properties for replacing sugar and glucose syrups in the preparation of low calorie, weakly cariogenic, bifidogenic and/or diet products.
The present invention ~is illustrated by a non-limiting range of examples of possible applications.
As base product, a syrup of branched fructo oligosaccharides, prepared as described in Example 1 or Example 2, was used.
The products according to the invention were evaluated by a panel of about twenty tasters in order to compare their properties with those of conventional products based on sucrose and/or glucose syrup. These tests revealed a high acceptance of products based on branched fructo-oligosaccharides.
EXAMPLE 3: Preparation of a milk ice cream Ingredients (by weight):
Skimmed milk powder 13.00 Water 62.46 Cream (35% fatty matter) 8.60 Branched fructo-oligosaccharides of 15.00 Example 1 Stabilizer (Cremodan SE30~ Grindsted 0.50 Products ) Vanilla flavoring agent (Silesia 0.40 111/8309280)~
Aspartame (NutraSweet)~ 0.04 ~

Composition:
Total solids 28.5%
Milk solids 16.0%
Milk fats 3.0%
Preparation:
The various ingredients in powder form are mixed While dry and dissolved in water.
The branched fructo-oligosaccharides, the flavor ing agent and the cream are then added. The whole is mixed until a homogeneous product is obtained.
The mi::cture is heated to 80'C and this tempera-ture is maintained for 30 seconds . The mixture is then homogenized while hot (mixer) , cooled to 5'C
and lE:ft to stand for a few hours in the refrigerator. It is aerated (100%) and frozen in an ice cream making machine (Carpigiani)~
It is stored in a deep freeze.
~XAMpLE 4: Preparation of a sorbet Incredients (by weight):
' Strawberry purEe (6.5% solids) 74.48 Branched fructo-oligosaccharides of 25.00 Examples 1 Stabil:Lzer (Fructodan SL64~ Grinsted 0.45 Products) Aspartame (NutraSweet) 0.07 Composition: 2:i% solids.
reparation:
The ingredients are thoroughly mixed, heated to 80'C and held at this temperature for 30 seconds.
The mixture is then cooled to 5'C and kept in the refrigerator for a few hours . It is aerated ( 75% ) and frozen in an ice cream making machine ( Carpigiani ) It is stored in a deep freeze .
EXAI~LE 5: Preparation of a iam Ingredients (by weight):
Strawberries (10% solids) 65.00 Branched fructo-oligosaccharides of 42.00 Example 1 ~

..
~ , WO 91/13076 - 18 - PCT/BE91/00014 Water 25.00 Pectin (LM 27NH95~ Sanofi Bio-Industrie) 1.00 Citric: acid ( 50% ) 0 . 80 Comvosition: 40% solids.
~regaration:
The pectin is dissolved in warm water ( 60'C) , and it is then thoroughly mixed with the straw berriea. The mixture is left to cook, with thorough stirring, until a product with a weight of 57 g is obtained.
The branched fructo-oligosaccharides, heated to 60'C, are then added. The citric acid is then added.. The mixture is allowed to cool to 75'C and is packed into glass jars.
EXAMPLE 6: Pre~earation of a yo hurt Ingredients (by weight) Whole milk (3.7% fatty~matter) 94.10 Skimms:d milk powder ~ 1.90 Yoghurt fermenting agents 1.00 Branched fructo-oligosaccharides of 3.00 Example 1 Composition:
Total solids 16.0%
Milk solids 13.5%
25~ Milk fats 3.5%
preparation:
The milk powder and the branched fructo-oligo-saccharides are mixed with the cold milk. The mixture is then heated to 6 0' C and homogenized .
3CI It is. then heated to 90'C and held at this temperature for 10 minutes.
The mixture is cooled to 45'C and is seeded with lactic fermenting agents. The mixture is trans ferred into preheated pots and incubated at 43'C
3:i to a ;pH o f 4 . 2 .
The product is stored at 10'C maximum.

~ WO 9I/13076 - 19 - PCT/BE91/00014 EXAMPLE 7: Preparation of a fruit cake Ingredients (by weight) Branched fructo-oligosaccharides of 25.30 Example 1 Margarine 8.50 Whole eggs 10.10 Ammonium carbonate/bicarbonate 0.40 Flour ~ 33.65 Milk 6.80 Raisins 10.10 Dried fruit 5.10 Acesulfame R ~ 0.05 Preparation:
Mix the branched fructo-oligosaccharides with the margarine, add the eggs, and the ammonium car bonate, the Acesulfame K and the bicarbonate dissolved in 0.5 liter of milk. Add the flour and the teat of the milk. Mix until a homogeneous mixture is obtained . Then add the rais ins and the dried fruit. Transfer the whole into a mold and bake in an oven at 250'C.
EXAMPLE 8: Preparation of a sponge cake Ingredients (by weight):
Branched fructo-oligosaccharides of 27.00 Example 1 Eggs 49.80 Flour 27.00 Butte=' 8.30 Acesul,fame K~(Fioechst) 0.05 Preparation:
Beat the branched fructo-oligosaccharides and the whole eggs in a bain-marie until a thick foam is obtained which has a density of t0.?5.
Sift the flour and add it to the paste while mixing~~ gently. Heat the butter until it is half melted and mix it with the dough. Pour the dough into a pregreased mold and cook in the oven for 20 minutes at 175'.

ERAI~LE 9: Preparation of cams Ingredients (by weight):
Branched fructo-oligosaccharides of 94.00 Example 2 Gelatin 200 BLS ~(Sanofi Bio-Industrie) 6.50 Water 13.50_ 50% citric acid solution 1.50-Cola LE 1613 ~(Sanofi Bio-Industrie) 0.10 Aspartame 0.26 Solids content of the finished product: 80%.
Preparation:
The gelatin is dissolved in hot water (80' to 90'C). The branched fructo-oligosaccharides are cooked at 115'C. The syrup is then cooled to 100'C. The gelatin solution is then added to this syrup. The air bubbles are removed from this syrup by bringing it under vacuum or by leaving it to stand.. The mass is cooled to approximately 80°C. The flavoring agent, the colorant, Aspartame and citric acid are added and the mixture is poured into starch molds. The starch is used at a temperature of approximately 30'-35'C. The gums ate covered with a starch . layer and are left to stand for 24 hours at room temperature. The powder is then removed from the gums and the latter are coated with oil.
~,XAMPLE 10: preparation of hard cams ~nqredients (by weight):
Branched fructo-oligosaccharides of 96.50 . Example 2 Gelatin GAT 15 ~ 11.00 Water 16.50 50% citric acid solution 1.50 Mandarin flavoring agent LE 1450~(Sanofi 0.25 Bio-Industries) Aspartame,~ . ~ 0.28 Solids content of the finished product: 88%.
~revaration:
The gelatin is dissolved in hot water (80'-90'C) .

~ WO 91/13076 - 21 - PCT/BE9I/00014 The branched fructo-oligosaccharides are cooked at 113''C. The syrup is then cooled to 100'C. The gelatin solution is then added to this syrup. The air bubbles are removed from this syrup and the mass is cooled to approximately 80'C. The flavor-ing agent, the colorant, Aspartame and citric_ acid are added. The mixture is poured into starch .
molds. The starch is used at a temperature of approximately 30'-35'C.
The gums are covered with a starch layer.
They a:re left to stand in a ventilated oven for ? 2 hours at 5 0' C . The powder is then removed from the gums and the latter are coated with oil.
EX,AI~LE 11: preparation of hard sweets Ingredients (by weight):
Branched fructo-aligosaccharides of 125.00 Example 1 Citric acid (100%) 0.83 Extract HE4017~(Sanofi Bio-Industrie) 0.10 Lemon :Flavoring agent LE 1616~(Sanofi~ 0.15 Bio-Industrie) Acesul:fame K ~ 0 . 34 Solids content of the finished product: 98%.
,Preparation: , The branched fructo-oligosaccharides are heated at a temperature of 165'C until a solids content of 98% is obtained.
. The syrup is cooled to a temperature of t110'C;
the colorant, the flavoring agent, Acesulfame R
and citric acid are then mixed with the product obtained. The product obtained is then poured into molds . After cooling, the sweets are removed from the molds.
EXAI~LE 12: Preparation of caramels ~nqredients (by weight) Branched fructo-oligosaccharides of 68.60 Example 1 Sweetened condensed milk 26.00 Fat melting at 32'C 5.20 ' WO 91/13076 - 22 - PCT/BE91/00014 Salt 0.20 Lecithin 0.20 Acesul:Eame R. ~ 0 .24 Preparation:
Dissolve the lecithin in the fat in a bain-marie at 70'C.
Pour the branched fructo-oligosaccharides, the~-sweetened condensed milk, the salt, Acesulfame R
and the mixture consisting of fat and lecithin into a cooking pot. Mix and heat the mixture to 55-60'C.
Raise the temperature to 119-121'C. Then pour onto a cooling tray and allow to cool to 35-40'C.
EXA1~LE 13: Preparation of a_puddinq Ineredients (by weight):
Skimmed milk 84.94 Skimmed milk powder 1.80 - Branche:d fructo-oligosaccharides of 10.00 ExamplE: 1 Aspart~une (NutraSweet)~ 0.03 Starch (Snowflake 06304~ Cerestar) 3.00 Carrageenan (Genulacta SGI-1 ~ Hercules) 0.20 vanilla flavoring agent (Flav-o-lok 0.02 630019H ~ PFW Products) Cream-yellow colorant (51798,.Ned. 0.01 Kleurstofindustrie) Comt~ositions 20% solids .
Preparation:
The ingredients in powder form are mixed while dry; the cold milk is then added. The ingredients are then mixed until a homogeneous mixture is obtained.
The mixture .is heated to 95'C and is held at this temperature for 5 minutes.
The whole is cooled to 50'C while stirring the mixture. The mixture is packed into dishes and stored in the refrigerator.

~X,AI~LE 14: Preparation of a fruit-based drink Ingredients (by Weight):
Concentrated fruit juice (Orange PG31332 ~ 3.80 Quest Int.) Branched fructo-oligosaccharides of 7.00 Example 1 Sucrose 7.50 Citric acid (50%) 0.30 Water 81.40 Composition:
Solids 14.5%
Fruit juice 15.0%
Freoaration:
Dissolve the sugar in the water . Add the other ingredients and mix thoroughly. Store in the refrigerator.
Examgle 15: Enzymatic treatment of inulin A 40 Brix solution, consisting of 50% sucrose and 50% inu.lin, which contains a large proportion of molecules with a high degree of polymerization (DP), 3.s adjusted to a pH of 5.4. This solution is divided into two fractions.
A solution of levansucrase (LS) is added to the first ;fraction so as to obtain 2 U of levan sucrase per gram of solid while bringing the pH
to 5. The solution is then incubated at 37'C for 18 hours. The enzymatic reaction is then halted by cooking the reaction mixture for five minutes .
0.6 U o~f endoinulase, obtained from the enzymatic preparation of Novozyme 230, per gram of solid is added i:o the second fraction. The incubation is halted after one hour by cooking the reaction mixture: for five minutes. A solution of levansucrase is then added as described above.
The percentage of precipitation in an 80% ethanol solution is determined for the various fractions 2~~~~~j.~'~

~ of precipitate calculated for all the products with DP > 2 Base solution 66 Base solution + LS 40 Base solution + endoinul. 15 Base solution -f endoinul. + LS 2.5 This shows that the action of l.evansucrase has a significant effect on the solubility of linear carbo-hydrates of the inulin type. It is evident that other linear chains, e.g. based on 2>6 (phlein type) bonds can also be branched by using a suitable enzyme, which preferentially forms other bonds than those of the linear chain such as, for example, of the 2-~l type (fructosyl transferase). This technique could even be applied to glucoside chains.
By starting from an inulin with a mean DP
markedly lower than that used in the example, e.g. by starting from the inulin of Jerusalem artichoke, levan sucrase can be made to act directly on the inul.i.n without prior hydrolysis.
In tabular form, the gas phase chromatographic analysis of the various fractions. As can be seen from this table, an increase is recorded in the proportion of products with DP 5, DP 6, DP 7, DP 8, DP 9 and DP 10 and of soluble products which it was not possible to separate by means of the column used (DP 10+). In addition, it is possible to see on the chromatogram that the shape of certain peaks of the reaction product is different from the peaks of the starting material (the presence of a shoulder, showing the presence of two products) and that, in addition, other products have been formed which can no longer be found in the chromatogram of the levan. This clearly shows that levansucrase has transferred fructose molecules from the sucrose to the linear chain.
Glucose is then removed from the fraction which was treated with endoinulase and levansucrase by fermen-tation. The product thus obtained is permethylated by following the slightly modified method described in the paper by Goran Larson et al.: ~~Application of a simple REPLACEMENT SHEET

rnethylation procedure for the analysis of glycosphingo-lipids", published in Carbohydrate Research, Vol. 161, p.
2$1-290 (1987).
After the permethylation,, the hydrolysis which makes it possible to produce monosaccharides and the silylation of 'the monosaccharides, the latter are sepa rated into dimethyl-, trimethyl- and tetramethylfructoses by gas phase chromatography. The presence of dimethyl fructose in the chromatogram is proof of the presence in the saccharide chains of fructose molecules bonded to three other molecules. In addition, it is possible to detect isomers of trimethylfructose such as 3,4,6- and 1,3,4-trimethylfructose which indicates the presence in the molecules of 1-»2 and 2-~6 bonds. This clearly proves that the action of levansucrase on the linear chain of the inulin gives rise to branching points both of the type:
Frul 2Fru1 2Fru 2Fru and of the type:
Frul 2Fru6 2Fru Table I which follows shows the result of the gas phase chromatographic analysis of the various fractions of the products of Example 15.

I

TABLE I

INULIN+SUCROSE A+I~SA+ENDO lhr B+LS

{50/50) {A) (B) Fructose 1.3 4.8 1.4 3.6 Glucose 0.45 28 0.5 26.4 Sucrose 49.7 9.5 51.4 4.6 DFA 0.2 0.3 0.3 0.2 F2 0.4 0.2 0.4 0.3 GF2 1.3 0.6 1.3 0.8 F3 1.6 0.01 6.5 2 GF3 1.8 0.7 2 1 F4 1.0 0.1 5.5 4.5 GF4 2 0.9 4.3 1.6 F5 0.4 2.4 3 4,9 GF5 1.8 0.9 3.7 2.5 F6 0.3 0.2 2 3.2 GF6 1.4 1 3 2.9 F7 0.1 0.1 1.:.~ 2.7 GF7 1.2 1.1 1.2 3 F8 0.1 0.2 0.3 2.3 GF8 1 1.3 0.6 2.8 F9 0.05 0.1 0.2 DP10 0.2 1.1 0 1.8 DP10+ 0 22 3.8 27 Precipitate 33 23.5 7.1 1.7 (DFA = Di-Fructose Anhydride) ItEPLAGEMEP1T SHEET

Claims (31)

1. Branched fructo-oligosaccharide consisting of a main chain and of one or more side chains, characterized in that the main chain and the side chain(s) consist mainly of fructose units, the main chain contains from 2 to 15 units and at least one branching point on one fructose unit, the branching at said at least one branching point consisting of a fructose-fructose bond, with the exception of the natural products: kestose, O-.beta.-D-fructofuranosyl-(2~1)-O-[O-.beta.-D-fructofuranosyl-(2~6)]-.beta.-D-fructofuranosyl-.alpha.-D-glucopyranoside, O-.beta.-D-fructofuranosyl-(2~1)-.beta.-D-fructofuranosyl-(2~1)-O-[O-.beta.-D-fructofuranosyl-(2~6)]-.beta.-D-fructofuranosyl-.alpha.-D-glucopyranoside and products having the following structure:

a) X = Glu1 n = 2 ~Y = 2Fru b) X = Glu1 n = 3 Y = 2Fru6-2Fru c) X = Fru1 n = 3 ~Y = 2Fru6-2Fru d) X = Glu1 n = 3 ~Y = 2Fru e) X = Glu1-2Fru6 n = 2 f) X = Glu1 n = 1 ~Y = -(2Fru6)-m; m = 1 to 12
2. Branched fructo-oligosaccharide according to claim 1, characterized in that the main chain consists of fructose units.
3.. Branched fructo-oligosaccharide according to claim 1 or 2, characterized in that the side chain(s) consist(s) of 1 to 15 units.
9:. Branched fructo-oligosaccharide according to any one of the claims 1 to 3, characterized in that the side chain(s) consist(s) of fructose units.
5. Branched fructo-oligosaccharide according to any one of the claims 1 to 4, characterized in that the side chain(s) is/are unbranched.
6. Branched fructo-oligosaccharide according to any one of the claims 1 to 4, characterized in that one or more side chains are, in their turn, branched into additional side chairs.
7. Process for the preparation of branched fructo-oligosaccharides according to any one of the claims 1 to 6, characterized in that the said fructo-oligosaccharides are obtained by extraction and partial hydrolysis of branched fructans, or from vegetable sources containing the said fructans.
8. Process for the preparation of branched fructo-oligosaccharides according to any one of the claims 1 to 6, characterized in that the said fructo-oligosaccharides are obtained by enzymatic synthesis, which synthesis involves reaction of saccharides containing fructose of which said fructose acts on at least one fructo-oligosaccharide, used as substrate, by using an enzyme which forms fructose-fructose bonds other than those which exist in the fructo-oligosaccharide used as a substrate.
9. Process according to clam 8, characterized in that a fructosyltransferase is used which forms bonds other than those present in the main chain of the fructo-oligosaccharide used as substrate.
10. Process for the preparation of branched fructo-oligosaccharides according to any one of the claims 1 to 6, characterized in that the said branched fructo-oligosaccharides are obtained by enzymatic synthesis from saccharides containing fructose by using, simultaneously or not, several enzymes which form different bonds.
11. Process for the preparation of branched fructo-oligosaccharides, characterized in that the said fructo-oligosaccharides are obtained by a combination of the processes of claims 7 to 10.
12. Process for improving the solubility of linear fructans, characterized in that a branching reaction is carried out by means of a process according to any one of claims 8 to 11.
13. Process for improving the solubility of linear fructans according to claim 12, the linear fructan being inulin.
14. Composition, characterized in that it consists of one or more branched fructo-oligosaccharides according to any one of claim 1 to 6, and other ingredients, consisting of at least one selected from the group consisting of proteins, lipids, fatty acids, carbohydrates, dietary fibres, bulking agents and additives.
15. Composition according to claim 14, wherein the bulking agents are selected from the group consisting of polydextrose, cellulose, and hemicellulose, fructo-oligosaccharides and other oligosaccharides.
16. Composition according to claim 15, wherein the additives are from the following list consisting of sweeteners, sugar alcohols, fructo-oligosaccharides, other oligosaccharides and sweeteners with a high sweetening power.
17. Composition according to claim 16 wherein the sweeteners are from the following list consisting of sucrose, glucose, fructose, hydrolysis products of starch, palatinose;

the sugar alcohols are from the following list consisting of sorbitol, xylitol, erythritol, mannitol, maltitol, lactitol, isomalt and leucritol; and sweeteners with a high sweetening power are selected from the group consisting of aspartame R, acesultame R, saccharin R, stevia R, and sucralose R.
18. Composition according to claim 16 wherein the sweeteners with a high sweetening power are dipeptides.
19. Food for human beings or animals, characterized in that it comprises one or more fructo-oligosaccharides according to any one of claims 1 to 6 or a composition according to any one of claims 14 to 18.
20. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as a bulking agent,
21. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as a sweetener.
22. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as a low-calorie food.
23. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as a food which is less cariogenic than the corresponding food product using saccharose.
24. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as a bifidogenic agent.
25. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as an agent having a limiting effect on the growth of putrefactive bacteria.
26. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as an agent having a cholesterol level reducing effect.
27. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as an agent with a dietary fiber effect.
28. Use of the product according to any one of claims 1 to 6 or of the composition according to any one of claims 14 to 18 as an agent having a diuretic effect.
29. Pharmaceutical composition, characterized in that it comprises a branched fructo-oligosaccharide according to any one of the preceding claims 1 to 6 or a composition according to any one of claims 14 to 18, and a pharmaceutically acceptable carrier.
30. Pharmaceutical composition according to claim 29, characterized in that it additionally comprises a filler.
31. Process according to claim 12, wherein as a substrate is used a linear fructan or a linear fructan which, having regard to its degree of polymerization, has been subjected to partial hydrolysis.
CA002076647A 1990-02-23 1991-02-22 Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them Expired - Lifetime CA2076647C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9000213A BE1003826A3 (en) 1990-02-23 1990-02-23 Fructo-oligosaccharides branched, method for their production and use of products containing.
BE9000213 1990-02-23
PCT/BE1991/000014 WO1991013076A1 (en) 1990-02-23 1991-02-22 Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them

Publications (2)

Publication Number Publication Date
CA2076647A1 CA2076647A1 (en) 1991-08-24
CA2076647C true CA2076647C (en) 2001-10-02

Family

ID=3884689

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002076647A Expired - Lifetime CA2076647C (en) 1990-02-23 1991-02-22 Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them

Country Status (8)

Country Link
EP (1) EP0515456B1 (en)
JP (1) JP3066070B2 (en)
AU (1) AU7235491A (en)
BE (1) BE1003826A3 (en)
CA (1) CA2076647C (en)
DE (1) DE69101914T2 (en)
ES (1) ES2053322T3 (en)
WO (1) WO1991013076A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2061498A1 (en) * 1991-02-26 1992-08-27 Andrew C. Hoefler Fat substitute
BE1005438A4 (en) * 1991-10-04 1993-07-27 Raffinerie Tirlemontoise Sa Cream compositions containing fructan, their method of preparation and use compositions.
WO1992008368A1 (en) * 1991-09-30 1992-05-29 Wm. Wrigley Jr. Company Chewing gum containing fructooligosaccharides
DE4223051C2 (en) * 1992-07-14 1996-12-19 Rolf Paul Prof Dr Claus Use of dietary products to specifically inhibit the intestinal formation of 3-methyl indole in pigs
BE1006377A3 (en) * 1992-11-24 1994-08-09 Raffinerie Tirlemontoise Sa SEPARATION METHOD OF polydispersed composition SACCHARIDES, PRODUCTS OBTAINED BY THE METHOD AND USE OF PRODUCTS OBTAINED IN FOOD COMPOSITIONS.
PT677112E (en) * 1992-12-28 2003-08-29 Stichting Scheikundig Onderzoe METHOD OF OBTAINING TRANSGENIC PLANTS PRESENTING A MODIFIED FRUIT PATTERN
EP0679063B1 (en) * 1993-01-13 1996-09-11 Unilever Plc Fat-replacing ingredient
US5641759A (en) * 1993-05-26 1997-06-24 Purdue Research Foundation Animal husbandry methods and compositions therefor
DE4320816C1 (en) * 1993-06-23 1994-08-25 Saric Krunoslav Animal feed having drinkable or chewable consistency
DE4341780A1 (en) * 1993-12-08 1995-06-14 Suedzucker Ag Hydrogenated fructooligosaccharides
JPH07322835A (en) * 1994-05-31 1995-12-12 Aohata Kk Low-calorie jams
NL9401140A (en) * 1994-07-08 1996-02-01 Stichting Scheikundig Onderzoe Production of oligosaccharides in transgenic plants
NL1000064C1 (en) 1994-07-08 1996-01-08 Stichting Scheikundig Onderzoe Production of oligosaccharides in transgenic plants.
US5431929A (en) * 1994-07-28 1995-07-11 Wm. Wrigley Jr. Company Chewing gum products using oligofructose
GB9512106D0 (en) * 1995-06-14 1995-08-09 Norsk Naeringsmiddelforskning Animal feed
ES2184847T5 (en) * 1996-07-31 2007-03-01 &quot;RAFFINERIE TIRLEMONTOISE&quot;, SOCIETE ANONYME LACTIC POWDERS CONTAINING FRUCTANE AND / OR POLYDEXTROSA, PROCEDURE FOR PREPARATION AND USE.
NL1005438C1 (en) * 1997-03-05 1998-09-08 Leuven K U Res & Dev Sweetener and food composition comprising such a sweetener.
JP4361140B2 (en) * 1997-04-18 2009-11-11 マクニール−ピーピーシー・インコーポレイテッド Delicious low-calorie fiber-containing sugar substitute
DE69837821T3 (en) * 1997-06-23 2015-05-28 Société des Produits Nestlé S.A. Composition for the nutrition of diabetics
US7186431B1 (en) 1998-08-27 2007-03-06 Barnard Stewart Silver Sweetening compositions and foodstuffs comprised thereof
US7147883B1 (en) 1998-08-27 2006-12-12 Silver Barnard S Compositions containing at least one polyol and inulin characterized by reduced tendencies of the at least one polyol to induce acute diarrhea
KR100993978B1 (en) 2002-04-26 2010-11-11 니혼 텐사이 세이토 가부시키가이샤 A composition for improving bowel movement
DE10303900A1 (en) * 2003-01-31 2004-08-12 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Synergistic cholesterol lowering composition, useful as medicament or food or feed additive, comprising dietary fiber component and ahypocholesterolemic agent, e.g. statin
IL181431A0 (en) * 2007-02-19 2007-07-04 Micha Shemer Fruit juice and puree with a lowered amount of available sugars
CA2957617A1 (en) * 2014-08-18 2016-02-25 Mofin S.R.L. Method for preparing milk-derived products based on cream, ricotta and mixtures thereof intended for quick-freezing or freezing, products obtained with said method and uses thereof
CN115028511A (en) * 2022-07-09 2022-09-09 浙江华康药业股份有限公司 Preparation method of sorbitol solution

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2629985B1 (en) * 1988-04-14 1994-01-21 Roussel Uclaf APPLICATION AS LOW-CALORIC SUGAR PRODUCTS OF FRUCTOSYLATED OLIGOSACCHARIDES AND FOODS, DIETETIC PRODUCTS AND BEVERAGES CONTAINING THEM

Also Published As

Publication number Publication date
CA2076647A1 (en) 1991-08-24
BE1003826A3 (en) 1992-06-23
JPH05504568A (en) 1993-07-15
EP0515456B1 (en) 1994-05-04
AU7235491A (en) 1991-09-18
JP3066070B2 (en) 2000-07-17
WO1991013076A1 (en) 1991-09-05
DE69101914T2 (en) 1994-08-18
EP0515456A1 (en) 1992-12-02
ES2053322T3 (en) 1994-07-16
DE69101914D1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
CA2076647C (en) Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them
US5659028A (en) Branched fructo-oligosaccharides, method for obtaining them and use of products containing them
Murphy Non-polyol low-digestible carbohydrates: food applications and functional benefits
JP6073265B2 (en) Fiber-containing carbohydrate composition
KR101760827B1 (en) Carbohydrate compositions
Moynihan Update on the nomenclature of carbohydrates and their dental effects
JP3602989B2 (en) Fat substitute food
AU2003245923B2 (en) Galactosyl isomalt, method for production and use thereof
KR101524991B1 (en) Food products comprising a slowly digestible or digestion resistant carbohydrate composition
JP4512135B2 (en) Functional sugar substitute
CA2292662A1 (en) Dietetic one-to-one sugar substitute composition for table top, baking and cooking applications
BRPI0707914A2 (en) functional sugar substitution
US11241022B2 (en) Short texture caramel
WO2014158777A1 (en) Fiber-containing carbohydrate composition
AU2003276966A1 (en) Condensed palatinose and method for producing the same
JP2018024619A (en) Endurance improver
JP2000515745A (en) Method for preparing polydisperse saccharide composition and obtained polydisperse saccharide composition
JP4982716B2 (en) Saccharide mixture, production method and use thereof
JP2004113146A (en) Honey-containing low-calorie and flowable liquid sweetener composition
JPS637760A (en) Preparation of low-cariogenic food and drink
IL165448A (en) Galactosyl isomalt compositions and methods for producing galactosyl isomalt

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry